United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 15, 2026 · Filed Jun 16, 2026

On Jun 15, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$549.15 for US$5.22M under a trading plan, leaving 40,513 shares. Filed Jun 16, 2026 (Form 4).

Sold
9,500 shares
Price
US$549.15 average (US$538.85 to US$553.47)
Value
US$5.22M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 15, 2026Common StockOption exercise9,500US$146.0350,013Direct
Jun 15, 2026Common StockSale75US$538.8549,938Direct
Jun 15, 2026Common StockSale205US$540.4349,733Direct
Jun 15, 2026Common StockSale200US$541.6149,533Direct
Jun 15, 2026Common StockSale440US$543.5149,093Direct
Jun 15, 2026Common StockSale809US$545.5148,284Direct
Jun 15, 2026Common StockSale470US$546.2247,814Direct
Jun 15, 2026Common StockSale482US$547.6347,332Direct
Jun 15, 2026Common StockSale1,459US$548.5345,873Direct
Jun 15, 2026Common StockSale732US$549.5645,141Direct
Jun 15, 2026Common StockSale1,768US$550.7243,373Direct
Jun 15, 2026Common StockSale1,180US$551.5742,193Direct
Jun 15, 2026Common StockSale760US$552.5941,433Direct
Jun 15, 2026Common StockSale920US$553.4740,513Direct

Source

View original at SEC

Related